ArcelorMittal South Africa Limited (ACL)
Johannesburg Stock Exchange · South Africa · prices in ZAC · close of 27 Oct 2026
Key indicators
| Last close | ZAC 133.00 |
|---|---|
| 52-week range | 101.00 – 164.00 |
| Return, 1 month / 3 months | −3.6% / −1.5% |
| Return, 1 year / 3 years | −13.6% / −0.7% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 56.6% |
| Worst drawdown (1 year) | -32.7% |
| Average daily value traded | 151.23M ZAC |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
ArcelorMittal South Africa makes steel, producing flat and long products at its plants in South Africa. Its customers come from construction, mining, automotive and general manufacturing, who use the steel for building, engineering and industrial goods. The company is based in South Africa and forms part of the wider ArcelorMittal steel group. It supplies both domestic and export markets with rolled steel products and related by-products.
The shares are listed on the Johannesburg Stock Exchange in South Africa under the code ACL, and the price on this page is in South African cents (ZAC). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
ArcelorMittal South Africa Limited (ACL) trades on the Johannesburg Stock Exchange in South Africa. It last closed at ZAC 133.00 on 27 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 155 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 13.6% and over the last three months it fell 1.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -14.7% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.5% | ||
| 6-month return | 0.8% | ||
| 12-month return, skipping the last month | -10.4% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 56.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.7% | ||
| Liquidity | 44 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 151.23M ZAC | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +25.5% |
|---|---|
| 1 month | −3.6% |
| 3 months | −1.5% |
| 6 months | +0.8% |
| 1 year | −13.6% |
| 3 years | −0.7% |
| 5 years | −80.4% |
Signals
| 50-day / 200-day average | 131.14 / 131.24 |
|---|---|
| Golden / death cross (60 days) | Death, 0 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.52 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.